Cor Vasa 2007, 49(4):123-124 | DOI: 10.33678/cor.2007.048

Několik mýtů o hypertrofické kardiomyopatii

Josef Veselka, David Zemánek
Kardiologické oddělení, Kardiovaskulární centrum, Fakultní nemocnice Motol, Praha, Česká republika

Published: April 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veselka J, Zemánek D. Několik mýtů o hypertrofické kardiomyopatii. Cor Vasa. 2007;49(4):123-124. doi: 10.33678/cor.2007.048.
Download citation

References

  1. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1-8. Go to original source... Go to PubMed...
  2. Linhart A. Nesarkomerické kardiomyopatie. V: Veselka J a spol. Hypertrofická kardiomyopatie a příbuzná témata. Praha: Galén, 2006.
  3. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006; 114:2232-9. Go to original source... Go to PubMed...
  4. Maron BJ, McKenna WJ, Danielson GK, et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy. Eur Heart J 2003;24:1965-91. Go to original source... Go to PubMed...
  5. Van Driest SL, Ommen SR, Tajik AJ, et al. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 2005;80:463-9. Go to original source... Go to PubMed...
  6. Kofflard MJ, Waldstein WJ, Vos J, ten Cate FJ. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993;72:970-2. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.